AZN
Price
$69.45
Change
-$1.68 (-2.36%)
Updated
Jul 3 closing price
Capitalization
208.98B
22 days until earnings call
SNYNF
Price
$98.33
Change
+$1.68 (+1.74%)
Updated
Jul 3 closing price
Capitalization
134.16B
Interact to see
Advertisement

AZN vs SNYNF

Header iconAZN vs SNYNF Comparison
Open Charts AZN vs SNYNFBanner chart's image
AstraZeneca
Price$69.45
Change-$1.68 (-2.36%)
Volume$6.77M
Capitalization208.98B
Sanofi
Price$98.33
Change+$1.68 (+1.74%)
Volume$327
Capitalization134.16B
AZN vs SNYNF Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. SNYNF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a StrongBuy and SNYNF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (AZN: $69.45 vs. SNYNF: $98.33)
Brand notoriety: AZN: Notable vs. SNYNF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 153% vs. SNYNF: 1%
Market capitalization -- AZN: $208.98B vs. SNYNF: $134.16B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, AZN is a better buy in the long-term than SNYNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 4 TA indicator(s) are bullish while SNYNF’s TA Score has 4 bullish TA indicator(s).

  • AZN’s TA Score: 4 bullish, 7 bearish.
  • SNYNF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, SNYNF is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а -0.88% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.13%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.13% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($209B) has a higher market cap than SNYNF($134B). AZN has higher P/E ratio than SNYNF: AZN (35.30) vs SNYNF (14.04). AZN YTD gains are higher at: 7.512 vs. SNYNF (3.398). SNYNF (13.8B) and AZN (13.4B) have comparable annual earnings (EBITDA) . SNYNF has more cash in the bank: 7.99B vs. AZN (5.86B). SNYNF has less debt than AZN: SNYNF (21B) vs AZN (28.6B). SNYNF (46.1B) and AZN (45.8B) have equivalent revenues.
AZNSNYNFAZN / SNYNF
Capitalization209B134B156%
EBITDA13.4B13.8B97%
Gain YTD7.5123.398221%
P/E Ratio35.3014.04251%
Revenue45.8B46.1B99%
Total Cash5.86B7.99B73%
Total Debt28.6B21B136%
FUNDAMENTALS RATINGS
AZN vs SNYNF: Fundamental Ratings
AZN
SNYNF
OUTLOOK RATING
1..100
5020
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
8
Undervalued
PROFIT vs RISK RATING
1..100
43100
SMR RATING
1..100
4675
PRICE GROWTH RATING
1..100
6058
P/E GROWTH RATING
1..100
8489
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNYNF's Valuation (8) in the null industry is in the same range as AZN (24) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (43) in the Pharmaceuticals Major industry is somewhat better than the same rating for SNYNF (100) in the null industry. This means that AZN’s stock grew somewhat faster than SNYNF’s over the last 12 months.

AZN's SMR Rating (46) in the Pharmaceuticals Major industry is in the same range as SNYNF (75) in the null industry. This means that AZN’s stock grew similarly to SNYNF’s over the last 12 months.

SNYNF's Price Growth Rating (58) in the null industry is in the same range as AZN (60) in the Pharmaceuticals Major industry. This means that SNYNF’s stock grew similarly to AZN’s over the last 12 months.

AZN's P/E Growth Rating (84) in the Pharmaceuticals Major industry is in the same range as SNYNF (89) in the null industry. This means that AZN’s stock grew similarly to SNYNF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNSNYNF
RSI
ODDS (%)
Bearish Trend 4 days ago
58%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
59%
Bullish Trend 4 days ago
47%
Momentum
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
46%
MACD
ODDS (%)
Bearish Trend 4 days ago
48%
Bullish Trend 4 days ago
53%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
46%
Bullish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
45%
Bullish Trend 4 days ago
48%
Advances
ODDS (%)
Bullish Trend 6 days ago
54%
Bullish Trend 4 days ago
49%
Declines
ODDS (%)
Bearish Trend 4 days ago
45%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
40%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
43%
Bearish Trend 4 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EWZS13.220.20
+1.54%
iShares MSCI Brazil Small-Cap ETF
DURA33.270.07
+0.20%
VanEck Durable High Dividend ETF
PSEP41.120.07
+0.18%
Innovator US Equity Power Buffer ETF-Sep
KEM27.58N/A
N/A
KraneShares Dynamic Emerging Markets Strategy ETF
IEI118.08-0.31
-0.26%
iShares 3-7 Year Treasury Bond ETF

SNYNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNYNF has been loosely correlated with SNY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if SNYNF jumps, then SNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
+1.74%
SNY - SNYNF
37%
Loosely correlated
-2.05%
NVSEF - SNYNF
24%
Poorly correlated
-3.76%
AZN - SNYNF
23%
Poorly correlated
-2.36%
JNJ - SNYNF
22%
Poorly correlated
N/A
NVS - SNYNF
21%
Poorly correlated
-1.54%
More